Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Tech Reporter.
Press releases published on March 20, 2025
Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights
GlobeNewswire
·
March 20, 2025
– Four development candidates in clinical studies with data anticipated this year, continuing rapid progress of antiviral pipeline – – Interim Phase 1b proof-of-concept data, including initial efficacy measures, anticipated in fall 2025 for ABI-5366 and …
TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 20, 2025
MALVERN, Pa., March 20, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today reported financial results for the fourth quarter and …
Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
GlobeNewswire
·
March 20, 2025
- Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with chemotherapy in first-line pancreatic cancer - - Announced a clinical trial supply agreement with Regeneron …
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
GlobeNewswire
·
March 20, 2025
Dose expansion in Phase 1 CARDINAL trial of TERN-701 for chronic myeloid leukemia (CML) expected to initiate in 2Q25 with additional safety and efficacy data in 4Q25 First patient enrolled in Phase 2 FALCON trial of TERN-601 for obesity with 12-week data …
SELLAS Life Sciences Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
March 20, 2025
– Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) with Next and Final Analysis Planned Upon Reaching 80 Events, Anticipated in 2025 – – Reported Positive Overall …
MacroGenics Provides Update on Corporate Progress and 2024 Financial Results
GlobeNewswire
·
March 20, 2025
Fully enrolled LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination with docetaxel in patients with mCRPC Initiating new LINNET Phase 2 study of lorigerlimab in ovarian cancer Advancing multiple novel topoisomerase 1 inhibitor- …
Senti Bio Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Pipeline and Corporate Highlights
GlobeNewswire
·
March 20, 2025
– Previously reported MRD negative CR in 2 of 3 relapsed/refractory AML patients enrolled in first dose level and schedule of Phase 1 clinical trial of SENTI-202 maintaining remission – – Strengthened balance sheet with gross proceeds of …
Erasca Reports Fourth Quarter and Full Year 2024 Business Updates and Financial Results
GlobeNewswire
·
March 20, 2025
Potentially best-in-class RAS-targeting franchise advancing with both ERAS-0015 and ERAS-4001 expected to enter the clinic in 2025 Ongoing Phase 3 SEACRAFT-2 registrational trial progressing well with Stage 1 randomized data expected in H2 2025 Robust …
Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 20, 2025
Enrollment completed in Phase 2a CBeyond™ trial of CB1 inhibitor, nimacimab, in obesity and overweight Faster-than-expected enrollment enables full top-line Phase 2a data in late Q3/early Q4 2025, ahead of schedule; interim analysis removed Phase 2a dosing …
Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd.
GlobeNewswire
·
March 20, 2025
BOSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it …
Vaxart Provides Business Update and Reports Full Year 2024 Financial Results
GlobeNewswire
·
March 20, 2025
Initiated Phase 1 clinical trial evaluating its second-generation oral norovirus vaccine constructs with topline data expected as early as mid-2025 Continues per protocol follow-up for the COVID-19 Phase 2b 400-person sentinel cohort Cash, cash equivalents …
Editas Medicine Announces Chief Financial Officer Transition
GlobeNewswire
·
March 20, 2025
Erick J. Lucera to Step Down as CFO to pursue another opportunity Senior Vice President of Finance Amy Parison Appointed CFO CAMBRIDGE, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today …
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
GlobeNewswire
·
March 20, 2025
TX45 Phase 1b trial interim analysis demonstrated meaningful improvements in both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (“PH-HFpEF”) Positive …
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
GlobeNewswire
·
March 20, 2025
Tegoprubart used as a key component of immunosuppression regimen in the second transplant of a genetically modified pig kidney into a human conducted at Massachusetts General Hospital Announced positive initial data from first three subjects with type 1 …
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025
GlobeNewswire
·
March 20, 2025
NEWTON, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the …
ARB IOT Group Limited Secures Additional Order for Its Smart IOT Palm Farming System, Strengthening Market Presence in Sabah
GlobeNewswire
·
March 20, 2025
Kuala Lumpur, Malaysia, March 20, 2025 (GLOBE NEWSWIRE) -- ARB IOT Group Limited ("ARB IOT" or the "Company") (NASDAQ: ARBB) is pleased to announce that its wholly-owned subsidiary, ARB Agro Technology Sdn Bhd, has secured an additional order to manage …
Micron Technology, Inc. Reports Results for the Second Quarter of Fiscal 2025
GlobeNewswire
·
March 20, 2025
Micron HBM revenue crosses $1 billion milestone in fiscal Q2 Strong execution and robust AI demand drives record data center DRAM revenue BOISE, Idaho, March 20, 2025 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced results for its …
Spectral AI Announces Public Filing of Registration Statement for Proposed Initial Public Offering of Spectral IP
GlobeNewswire
·
March 20, 2025
DALLAS, March 20, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration in 2018 and uses …
Hisense's Newest TV Sound System Combines Wireless Freedom with Immersive Sound
GlobeNewswire
·
March 20, 2025
SUWANEE, GA, March 20, 2025 (GLOBE NEWSWIRE) -- New TV audio system delivers immersive 5.1.4-channel Dolby Atmos® sound with True Wireless Rear Surround and Hi-Concerto Technology for a more cinematic experience Hisense, a global leader in consumer …
A' Office and Business Appliances Design Award Announces Final Call for Last Entries
EIN Presswire
·
March 20, 2025
Distinguished international design competition for office and business appliances extends last submission deadline to March 30, 2025 COMO, CO, ITALY, March 20, 2025 /EINPresswire.com/ -- The A' Office and Business Appliances Design Award, a highly …